Biogen (BIIB) Interest & Investment Income (2011 - 2012)
Biogen (BIIB) posted Interest & Investment Income of $2.2 million for Q2 2012, up 163.26% on a QoQ basis from $822000.0 in Q2 2011, and up 163.26% year-over-year from $822000.0 in Q3 2011.
Powered by 
Analysis
Biogen (BIIB) Interest & Investment Income (2011 - 2012) Analysis & Trends
Biogen has reported Interest & Investment Income for 2 years, with the latest figure at $2.2 million in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 67.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 48.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 36.92 Mn |
| 10 | Insmed | 26.19 Bn | 25.03 Bn | 358.27 Mn | 10.98 Mn |